SION Valuation

Sionna Therapeutics Inc

Add to Watchlist

Advanced Chart

21.390

+0.57(2.738%)1D

Overview
Forecast
Valuation
Earnings

SION Relative Valuation

SION's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SION is overvalued; if below, it's undervalued.

Historical Valuation

Sionna Therapeutics Inc (SION) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.70. The fair price of Sionna Therapeutics Inc (SION) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：21.39

Fair

-9.79

Trailing

Forward

-5.98

EV/EBITDA

Sionna Therapeutics Inc. (SION) has a current EV/EBITDA of -5.98. The 5-year average EV/EBITDA is -4.63. The thresholds are as follows: Strongly Undervalued below -9.14, Undervalued between -9.14 and -6.89, Fairly Valued between -2.38 and -6.89, Overvalued between -2.38 and -0.13, and Strongly Overvalued above -0.13. The current Forward EV/EBITDA of -5.98 falls within the Historic Trend Line -Fairly Valued range.

-5.34

EV/EBIT

Sionna Therapeutics Inc. (SION) has a current EV/EBIT of -5.34. The 5-year average EV/EBIT is -4.76. The thresholds are as follows: Strongly Undervalued below -9.59, Undervalued between -9.59 and -7.17, Fairly Valued between -2.35 and -7.17, Overvalued between -2.35 and 0.06, and Strongly Overvalued above 0.06. The current Forward EV/EBIT of -5.34 falls within the Historic Trend Line -Fairly Valued range.

0.00

Sionna Therapeutics Inc. (SION) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

-90.10

P/OCF

Sionna Therapeutics Inc. (SION) has a current P/OCF of -90.10. The 5-year average P/OCF is -11.88. The thresholds are as follows: Strongly Undervalued below -50.38, Undervalued between -50.38 and -31.13, Fairly Valued between 7.36 and -31.13, Overvalued between 7.36 and 26.61, and Strongly Overvalued above 26.61. The current Forward P/OCF of -90.10 falls within the Strongly Undervalued range.

-9.88

P/FCF

Sionna Therapeutics Inc. (SION) has a current P/FCF of -9.88. The 5-year average P/FCF is -6.92. The thresholds are as follows: Strongly Undervalued below -12.15, Undervalued between -12.15 and -9.54, Fairly Valued between -4.31 and -9.54, Overvalued between -4.31 and -1.70, and Strongly Overvalued above -1.70. The current Forward P/FCF of -9.88 falls within the Undervalued range.

Sionna Therapeutics Inc (SION) has a current Price-to-Book (P/B) ratio of 2.73. Compared to its 3-year average P/B ratio of 1.00 , the current P/B ratio is approximately 174.38% higher. Relative to its 5-year average P/B ratio of 1.00, the current P/B ratio is about 174.38% higher. Sionna Therapeutics Inc (SION) has a Forward Free Cash Flow (FCF) yield of approximately -6.97%. Compared to its 3-year average FCF yield of -8.43%, the current FCF yield is approximately -17.37% lower. Relative to its 5-year average FCF yield of -8.43% , the current FCF yield is about -17.37% lower.

2.73

P/B

Median3y

1.00

Median5y

1.00

-6.97

FCF Yield

Median3y

-8.43

Median5y

-8.43

Competitors Valuation Multiple

The average P/S ratio for SION's competitors is 386.75, providing a benchmark for relative valuation. Sionna Therapeutics Inc Corp (SION) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SION.O

Sionna Therapeutics Inc

Trevi Therapeutics Inc

Loss

907.24M

IOVA.O

Iovance Biotherapeutics Inc

Performance Decomposition

Market capitalization of SION increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of SION in the past 1 year is driven by Unknown.